Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Stanford University
AstraZeneca
Mayo Clinic
Aminex Therapeutics, Inc.
Hoffmann-La Roche
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Hummingbird Bioscience
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Mayo Clinic
Bayer
University of Florida
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Wake Forest University Health Sciences
Sapience Therapeutics
MacroGenics
City of Hope Medical Center
Daiichi Sankyo
Novartis
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Second Life Therapeutics
NRG Oncology
Onchilles Pharma Inc
University of Southern California
Innate Pharma
Novartis
The Netherlands Cancer Institute
OncoNano Medicine, Inc.
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Compass Therapeutics
NeoTX Therapeutics Ltd.
Abramson Cancer Center at Penn Medicine
Transgene
Bolt Biotherapeutics, Inc.
AstraZeneca
Bayer
M.D. Anderson Cancer Center
Tempus AI